CDK-TCIP2

Customer Review

Based on 1 Customer Validation

CDK-TCIP2 is an inhibitor targeting CDK9 and BCL6. CDK-TCIP2 recruits CDK9 to BCL6 binding sites and regulatory regions, phosphorylates RNA Pol II, and activates or silences gene transcription, thereby altering the function of BCL6 in germinal center B cells and reducing germinal center B cells. CDK-TCIP2 kills diffuse large B-cell lymphoma cells and can be used in research on diffuse large B-cell lymphoma.

For research use only. We do not sell to patients.

  • Purity : 98.94%
  • Formula: C52H67ClN12O8S2
  • Molecular Weight:1087.75
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00